Tebentafusp improves OS: A First in Metastatic Uveal Melanoma ...Middle East

News by : (Medscape) -
First-line tebentafusp significantly improved overall survival (OS) when compared with immunotherapy or chemotherapy in patients with metastatic uveal melanoma in a phase 3 trial. Medscape Medical News

Hence then, the article about tebentafusp improves os a first in metastatic uveal melanoma was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tebentafusp improves OS: A First in Metastatic Uveal Melanoma )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار